肠道清洁对炎症性肠病患者和健康对照者肠道菌群组成的影响

IF 4.2 3区 医学
Péter Bacsur, Mariann Rutka, András Asbóth, Tamás Resál, Kata Szántó, Boldizsár Jójárt, Anita Bálint, Eszter Ari, Walliyulahi Ajibola, Bálint Kintses, Tamás Fehér, Daniella Pigniczki, Renáta Bor, Anna Fábián, József Maléth, Zoltán Szepes, Klaudia Farkas, Tamás Molnár
{"title":"肠道清洁对炎症性肠病患者和健康对照者肠道菌群组成的影响","authors":"Péter Bacsur,&nbsp;Mariann Rutka,&nbsp;András Asbóth,&nbsp;Tamás Resál,&nbsp;Kata Szántó,&nbsp;Boldizsár Jójárt,&nbsp;Anita Bálint,&nbsp;Eszter Ari,&nbsp;Walliyulahi Ajibola,&nbsp;Bálint Kintses,&nbsp;Tamás Fehér,&nbsp;Daniella Pigniczki,&nbsp;Renáta Bor,&nbsp;Anna Fábián,&nbsp;József Maléth,&nbsp;Zoltán Szepes,&nbsp;Klaudia Farkas,&nbsp;Tamás Molnár","doi":"10.1177/17562848231174298","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In patients with inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC), numerous cases of exacerbations could be observed after colonoscopy, raising the possible pathogenetic effect of colonic microbiota alterations in IBD flare.</p><p><strong>Objectives: </strong>We aimed to investigate the changes in the fecal microbiota composition in IBD patients influenced by the bowel preparation with sodium picosulfate.</p><p><strong>Design: </strong>We enrolled patients with IBD undergoing bowel preparation for colonoscopy in the prospective cohort study. The control group (Con) comprised non-IBD patients who underwent colonoscopy. Clinical data, blood, and stool samples were collected before colonoscopy (timepoint A), 3 days later (timepoint B), and 4 weeks later (timepoint C).</p><p><strong>Methods: </strong>Disease activity and gut microbiota changes were assessed at each timepoint. Fecal microbiota structure - at family level - was determined by sequencing the V4 region of the 16S rRNA gene. Statistical analysis included differential abundance analysis and Mann-Whitney tests.</p><p><strong>Results: </strong>Forty-one patients (9 CD, 13 UC, and 19 Con) were included. After bowel preparation, alpha diversity was lower in the CD group than in the UC (<i>p</i> = 0.01) and Con (<i>p</i> = 0.02) groups at timepoint B. Alpha diversity was significantly higher in the UC group than in the CD and Con (<i>p</i> = 0.03) groups at timepoint C. Beta diversity difference differed between the IBD and Con (<i>p</i> = 0.001) groups. Based on the differential abundance analysis, the Clostridiales family was increased, whereas the <i>Bifidobacteriaceae</i> family was decreased in CD patients compared to the Con at timepoint B.</p><p><strong>Conclusions: </strong>Bowel preparation may change the fecal microbial composition in IBD patients, which may have a potential role in disease exacerbation after bowel cleansing.</p>","PeriodicalId":23022,"journal":{"name":"Therapeutic Advances in Gastroenterology","volume":"16 ","pages":"17562848231174298"},"PeriodicalIF":4.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265323/pdf/","citationCount":"1","resultStr":"{\"title\":\"Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.\",\"authors\":\"Péter Bacsur,&nbsp;Mariann Rutka,&nbsp;András Asbóth,&nbsp;Tamás Resál,&nbsp;Kata Szántó,&nbsp;Boldizsár Jójárt,&nbsp;Anita Bálint,&nbsp;Eszter Ari,&nbsp;Walliyulahi Ajibola,&nbsp;Bálint Kintses,&nbsp;Tamás Fehér,&nbsp;Daniella Pigniczki,&nbsp;Renáta Bor,&nbsp;Anna Fábián,&nbsp;József Maléth,&nbsp;Zoltán Szepes,&nbsp;Klaudia Farkas,&nbsp;Tamás Molnár\",\"doi\":\"10.1177/17562848231174298\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In patients with inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC), numerous cases of exacerbations could be observed after colonoscopy, raising the possible pathogenetic effect of colonic microbiota alterations in IBD flare.</p><p><strong>Objectives: </strong>We aimed to investigate the changes in the fecal microbiota composition in IBD patients influenced by the bowel preparation with sodium picosulfate.</p><p><strong>Design: </strong>We enrolled patients with IBD undergoing bowel preparation for colonoscopy in the prospective cohort study. The control group (Con) comprised non-IBD patients who underwent colonoscopy. Clinical data, blood, and stool samples were collected before colonoscopy (timepoint A), 3 days later (timepoint B), and 4 weeks later (timepoint C).</p><p><strong>Methods: </strong>Disease activity and gut microbiota changes were assessed at each timepoint. Fecal microbiota structure - at family level - was determined by sequencing the V4 region of the 16S rRNA gene. Statistical analysis included differential abundance analysis and Mann-Whitney tests.</p><p><strong>Results: </strong>Forty-one patients (9 CD, 13 UC, and 19 Con) were included. After bowel preparation, alpha diversity was lower in the CD group than in the UC (<i>p</i> = 0.01) and Con (<i>p</i> = 0.02) groups at timepoint B. Alpha diversity was significantly higher in the UC group than in the CD and Con (<i>p</i> = 0.03) groups at timepoint C. Beta diversity difference differed between the IBD and Con (<i>p</i> = 0.001) groups. Based on the differential abundance analysis, the Clostridiales family was increased, whereas the <i>Bifidobacteriaceae</i> family was decreased in CD patients compared to the Con at timepoint B.</p><p><strong>Conclusions: </strong>Bowel preparation may change the fecal microbial composition in IBD patients, which may have a potential role in disease exacerbation after bowel cleansing.</p>\",\"PeriodicalId\":23022,\"journal\":{\"name\":\"Therapeutic Advances in Gastroenterology\",\"volume\":\"16 \",\"pages\":\"17562848231174298\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265323/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562848231174298\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562848231174298","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景:在炎症性肠病(IBD)、克罗恩病(CD)和溃疡性结肠炎(UC)患者中,结肠镜检查后可观察到许多加重病例,这提高了结肠微生物群改变在IBD发作中的可能致病作用。目的:我们的目的是调查肠准备pico硫酸钠对IBD患者粪便微生物群组成的影响。设计:我们在前瞻性队列研究中招募了接受结肠镜检查肠道准备的IBD患者。对照组(Con)由接受结肠镜检查的非ibd患者组成。在结肠镜检查前(时间点A)、3天后(时间点B)和4周后(时间点C)收集临床资料、血液和粪便样本。方法:在每个时间点评估疾病活动性和肠道微生物群变化。通过对16S rRNA基因的V4区进行测序,确定了家族水平的粪便微生物群结构。统计分析包括差异丰度分析和Mann-Whitney检验。结果:纳入41例患者(CD 9例,UC 13例,Con 19例)。肠准备后,在b时间点,CD组的α多样性低于UC组(p = 0.01)和Con组(p = 0.02)。在c时间点,UC组的α多样性显著高于CD组和Con组(p = 0.03)。根据差异丰度分析,在时间点b,与对照组相比,CD患者的Clostridiales家族增加,而Bifidobacteriaceae家族减少。结论:肠道准备可能改变IBD患者的粪便微生物组成,这可能在肠道清洁后疾病加重中起潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

Background: In patients with inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC), numerous cases of exacerbations could be observed after colonoscopy, raising the possible pathogenetic effect of colonic microbiota alterations in IBD flare.

Objectives: We aimed to investigate the changes in the fecal microbiota composition in IBD patients influenced by the bowel preparation with sodium picosulfate.

Design: We enrolled patients with IBD undergoing bowel preparation for colonoscopy in the prospective cohort study. The control group (Con) comprised non-IBD patients who underwent colonoscopy. Clinical data, blood, and stool samples were collected before colonoscopy (timepoint A), 3 days later (timepoint B), and 4 weeks later (timepoint C).

Methods: Disease activity and gut microbiota changes were assessed at each timepoint. Fecal microbiota structure - at family level - was determined by sequencing the V4 region of the 16S rRNA gene. Statistical analysis included differential abundance analysis and Mann-Whitney tests.

Results: Forty-one patients (9 CD, 13 UC, and 19 Con) were included. After bowel preparation, alpha diversity was lower in the CD group than in the UC (p = 0.01) and Con (p = 0.02) groups at timepoint B. Alpha diversity was significantly higher in the UC group than in the CD and Con (p = 0.03) groups at timepoint C. Beta diversity difference differed between the IBD and Con (p = 0.001) groups. Based on the differential abundance analysis, the Clostridiales family was increased, whereas the Bifidobacteriaceae family was decreased in CD patients compared to the Con at timepoint B.

Conclusions: Bowel preparation may change the fecal microbial composition in IBD patients, which may have a potential role in disease exacerbation after bowel cleansing.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology Medicine-Gastroenterology
自引率
2.40%
发文量
103
期刊介绍: Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信